JHS Svendgaard Laboratories Operational Benchmarking
₹9.64+0.10%close, 9 Oct 2026
- Market cap
- ₹84.26 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹6.94 – ₹13.01
JHS Svendgaard Laboratories compared with sector peers on revenue, market capitalization, valuation, and return metrics.
JHS Svendgaard Laboratories sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| JHS Svendgaard Laboratories Limited | ₹9.64 | 22.5 | 84.26 | 1.2% | 21.07 | 14.5% |
| Median (1 Cos) | ₹9.64 | 22.5 | 84.26 | 1.2% | 21.07 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Jupiter Life Line Hospitals Limited operational benchmarking
- Jagsonpal Pharmaceuticals Limited operational benchmarking
- Jubilant Pharmova Limited operational benchmarking
- IPCA Laboratories Limited operational benchmarking
- Kilitch Drugs (India) Limited operational benchmarking
- IOL Chemicals and Pharmaceuticals Limited operational benchmarking
Trade JHS Svendgaard Laboratories With ATS
Track JHS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.